| 2004 WHO classification of the renal tumors of the adults A Lopez-Beltran, M Scarpelli, R Montironi, Z Kirkali European urology 49 (5), 798-805, 2006 | 1125 | 2006 |
| Metabolic phenotype of bladder cancer F Massari, C Ciccarese, M Santoni, R Iacovelli, R Mazzucchelli, F Piva, ... Cancer treatment reviews 45, 46-57, 2016 | 226 | 2016 |
| 2009 update on the classification of renal epithelial tumors in adults A Lopez‐Beltran, JC Carrasco, L Cheng, M Scarpelli, Z Kirkali, ... International Journal of Urology 16 (5), 432-443, 2009 | 199 | 2009 |
| Immune checkpoint inhibitors for the treatment of bladder cancer A Lopez-Beltran, A Cimadamore, A Blanca, F Massari, N Vau, M Scarpelli, ... Cancers 13 (1), 131, 2021 | 183 | 2021 |
| Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology … R Montironi, R Mazzuccheli, M Scarpelli, A Lopez‐Beltran, G Fellegara, ... BJU international 95 (8), 1146-1152, 2005 | 175 | 2005 |
| Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate R Montironi, R Mazzucchelli, A Lopez-Beltran, L Cheng, M Scarpelli Nature Clinical Practice Urology 4 (6), 321-332, 2007 | 153 | 2007 |
| Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? SS Shen, LD Truong, M Scarpelli, A Lopez-Beltran Archives of Pathology & Laboratory Medicine 136 (4), 410-417, 2012 | 142 | 2012 |
| Neuroendocrine tumours of the urinary system and male genital organs: clinical significance R Mazzucchelli, D Morichetti, A Lopez‐Beltran, L Cheng, M Scarpelli, ... BJU international 103 (11), 1464-1470, 2009 | 124 | 2009 |
| Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications G Aurilio, A Cimadamore, R Mazzucchelli, A Lopez-Beltran, E Verri, ... Cells 9 (12), 2653, 2020 | 120 | 2020 |
| Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment B Marconi, I Bobyr, A Campanati, E Molinelli, V Consales, V Brisigotti, ... Intractable & rare diseases research 4 (3), 113-122, 2015 | 119 | 2015 |
| MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas M Scarpelli, U Salvolini, L Diamanti, R Montironi, L Chiaromoni, ... Neuroradiology 36, 393-398, 1994 | 107 | 1994 |
| Rare and unusual histological variants of prostatic carcinoma: clinical significance R Mazzucchelli, A Lopez‐Beltran, L Cheng, M Scarpelli, Z Kirkali, ... BJU international 102 (10), 1369-1374, 2008 | 102 | 2008 |
| Epithelial to mesenchymal transition in renal cell carcinoma: implications for cancer therapy F Piva, M Giulietti, M Santoni, G Occhipinti, M Scarpelli, A Lopez-Beltran, ... Molecular diagnosis & therapy 20, 111-117, 2016 | 99 | 2016 |
| BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies F Piva, M Santoni, MR Matrana, S Satti, M Giulietti, G Occhipinti, F Massari, ... Expert review of molecular diagnostics 15 (9), 1201-1210, 2015 | 99 | 2015 |
| Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? R Montironi, R Mazzucchelli, A Lopez-Beltran, G Martignoni, L Cheng, ... European urology 54 (6), 1237-1246, 2008 | 99 | 2008 |
| Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer A Lopez-Beltran, RJ Luque, R Mazzucchelli, M Scarpelli, R Montironi Journal of clinical pathology 55 (9), 641-647, 2002 | 98 | 2002 |
| PD-L1 assessment in urothelial carcinoma: a practical approach M Eckstein, A Cimadamore, A Hartmann, A Lopez-Beltran, L Cheng, ... Annals of Translational Medicine 7 (22), 2019 | 91 | 2019 |
| Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives M Santoni, A Conti, L Burattini, R Berardi, M Scarpelli, L Cheng, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 630-637, 2014 | 91 | 2014 |
| Pathology and genetics: tumours of the urinary system and male genital system: clinical implications of the 4th Edition of the WHO classification and beyond. R Montironi, L Cheng, M Scarpelli, A Lopez-Beltran European urology 70 (1), 120-123, 2016 | 88 | 2016 |
| Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens R Montironi, R Mazzucchelli, A Santinelli, M Scarpelli, AL Beltran, ... Human pathology 36 (6), 646-654, 2005 | 87 | 2005 |
